Company Information
Industry 卫生和社会工作业
Company Introduction 公司前身系成都普瑞眼科医院有限责任公司(以下简称成都普瑞有限公司),成都普瑞有限公司系由自然人徐旭阳和广州鑫视康医疗器械有限公司共同出资组建,于2006年3月23日在成都市工商行政管理局登记注册,取得注册号为510106000289420的企业法人营业执照,成立时注册资本1,000万元。成都普瑞有限公司以2016年7月31日为基准日,整体变更为股份有限公司,于2016年11月15日在成都市工商行政管理局登记注册,总部位于四川省成都市。公司现持有统一社会信用代码为91510106785430077J营业执照,注册资本11,221.4286万元,股份总数11,221.4286万股(每股面值1元)。 公司是一家集门诊、临床、医疗和医疗技术开发为一体的专业连锁眼科医疗机构,主营业务为向眼科疾病患者提供专业的眼科医疗服务。公司的产品或服务主要包括屈光项目、白内障项目、医学视光项目和综合眼病项目,具体包含了屈光手术、医学验光配镜、白内障、青光眼、斜弱视与小儿眼病、眼底病、眼整形及泪道、角膜病等眼科全科诊疗项目。公司采取“直营连锁”的经营模式,通过下属各连锁医院为眼病患者提供眼科医疗服务。公司自设立之日起,主要通过在直辖市、省会城市等重点城市进行医院布局,进而辐射周边。公司已在全国多个直辖市和省会城市共拥有23家专业眼科医院、3家眼科门诊部。除此之外,公司还拥有专业眼病研究所,为公司开展眼科医疗服务提供技术支持。从连锁医院布局城市数量来看,发行人已在全国20个城市进行业务布局,拥有眼科领域的医疗服务人员超过1,000人,在同行业竞争者中处于相对优势地位。
Main Business 为向眼科疾病患者提供专业的眼科医疗服务。
Legal Representative 徐旭阳
Top Executives
董事长:徐旭阳
董事:熊小聪,曹长梁,孙强
独立董事:陈鹏辉,汤华东,陈凌云
Top 5 Shareholder
Shareholder name Nature Holding Date
成都普瑞世纪投资有限责任公司限售股35.91%31/03/2024
徐旭阳限售股6.75%31/03/2024
扶绥正心投资合伙企业(有限合伙)限售股4.01%31/03/2024
扶绥锦官青城投资合伙企业(有限合伙)限售股3.11%31/03/2024
北京红杉铭德股权投资中心(有限合伙)流通A股3.01%31/03/2024
Company Secretary 金亮
Solicitors 北京国枫律师事务所
Auditors 天健会计师事务所(特殊普通合伙)
Tel No 021-52990538
Fax No 021-62597666-304
Website www.purui.cn
Email ir@purui.cn
Company Address
Register: 四川省成都市金牛区一环路北四段215号
Office: 上海市长宁区茅台路899号
Listing Date 05/07/2022
Shares Capital
Shares Capital: 149,619,048
Total A Share: 149,619,048
Listed A Share: 70,034,196
Non-tradable A Share: 79,584,852
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 1.790
DPS(RMB)* ¥ 0.400
NBV Per Share(RMB)* ¥ 15.316
Market Capitalization(RMB) 3.348B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.